{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:41Z","timestamp":1788355361031,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The 2013 HIV Organ Policy Equity (HOPE) Act expanded kidney transplantation eligibility for people with HIV\/AIDS (PWH), marking a significant milestone and necessitating updated reviews on the outcomes of renal transplantations on PWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess kidney transplantation outcomes in PWH, including patient and graft survival, graft rejection, and infection rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a systematic review of studies published between 1990 and 2023. Included studies reported on kidney transplantation outcomes in PWH, focusing on graft and patient survival, rejection, and infections and compared with HIV-negative kidney graft recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Out of 743 studies, 49 prospective and retrospective studies were included, with data of 6174 PWHs analysed. At one year post-transplant, patient survival in PWH was high at 94% (95% CI: 92.83\u201394.97%), with a decrease to 83% beyond five years (95% CI: 76.50\u201387.64%). Graft survival exhibited similar trends. Graft rejection rates increased from 26% in one year to 39% over five years. There were no significant differences in short- to medium-term recipient survival rates between PWH and HIV-negative individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Kidney transplantation is a viable option for PWH, with short- to medium-term outcomes comparable to HIV-negative recipients. Future research should focus on optimizing long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11480-7","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:54:21Z","timestamp":1758880461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival of kidney transplantation in people living with HIV\/AIDS: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ka Chun","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wincy Wing Sze","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ciofani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"11480_CR1","unstructured":"AIDSinfo. | UNAIDS. https:\/\/aidsinfo.unaids.org\/ [Accessed 17 Nov 2023]."},{"issue":"12","key":"11480_CR2","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1111\/ajt.15500","volume":"19","author":"J Tourret","year":"2019","unstructured":"Tourret J, Guiguet M, Lassalle M, Grabar S, Li\u00e8vre L, Isnard-Bagnis C, et al. Access to the waiting list and to kidney transplantation for people living with HIV: a national registry study. Am J Transplant. 2019;19(12):3345\u201355. https:\/\/doi.org\/10.1111\/ajt.15500.","journal-title":"Am J Transplant"},{"issue":"19","key":"11480_CR3","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1111\/febs.15677","volume":"288","author":"R Goyal","year":"2021","unstructured":"Goyal R, Singhal PC. APOL1 risk variants and the development of HIV-associated nephropathy. FEBS J. 2021;288(19):5586\u201397. https:\/\/doi.org\/10.1111\/febs.15677.","journal-title":"FEBS J"},{"issue":"1","key":"11480_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-020-00266-3","volume":"17","author":"JE Heron","year":"2020","unstructured":"Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020;17(1): 11. https:\/\/doi.org\/10.1186\/s12981-020-00266-3.","journal-title":"AIDS Res Ther"},{"issue":"2","key":"11480_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MOT.0000000000000510","volume":"23","author":"BL Doby","year":"2018","unstructured":"Doby BL, Tobian AAR, Segev DL, Durand CM. Moving from the HIV organ policy equity act to HIV organ policy equity in action: changing practice and challenging stigma. Curr Opin Organ Transplant. 2018;23(2):271\u20138. https:\/\/doi.org\/10.1097\/MOT.0000000000000510.","journal-title":"Curr Opin Organ Transplant"},{"key":"11480_CR6","unstructured":"CDC. Undetectable\u2009=\u2009Untransmittable, Global HIV. and TB. https:\/\/www.cdc.gov\/global-hiv-tb\/php\/our-approach\/undetectable-untransmittable.html [Accessed 15 Sept 2024]."},{"key":"11480_CR7","unstructured":"andrewswartz. Three years of HOPE. UNOS. https:\/\/unos.org\/news\/three-years-of-hope\/ [Accessed 13th May 2025]."},{"issue":"21","key":"11480_CR8","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","volume":"363","author":"PG Stock","year":"2010","unstructured":"Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1001197.","journal-title":"N Engl J Med"},{"issue":"7","key":"11480_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1408896","volume":"372","author":"E Muller","year":"2015","unstructured":"Muller E, Barday Z, Mendelson M, Kahn D. HIV-positive\u2013to\u2013HIV-positive kidney transplantation \u2014 results at 3 to 5 years. N Engl J Med. 2015;372(7):613\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1408896.","journal-title":"N Engl J Med"},{"issue":"2","key":"11480_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/TP.0b013e318177884e","volume":"86","author":"SA Gruber","year":"2008","unstructured":"Gruber SA, Doshi MD, Cincotta E, Brown KL, Singh A, Morawski K, et al. Preliminary experience with renal transplantation in HIV\u2009+\u2009recipients: low acute rejection and infection rates. Transplantation. 2008;86(2):269\u201374. https:\/\/doi.org\/10.1097\/TP.0b013e318177884e.","journal-title":"Transplantation"},{"issue":"1","key":"11480_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0956462413493266","volume":"25","author":"EN Gathogo","year":"2014","unstructured":"Gathogo EN, Hamzah L, Hilton R, Marshall N, Ashley C, Harber M, et al. Kidney transplantation in HIV-positive adults: the UK experience. Int J STD AIDS. 2014;25(1):57\u201366. https:\/\/doi.org\/10.1177\/0956462413493266.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"11480_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-019-0253-z","volume":"16","author":"X Zheng","year":"2019","unstructured":"Zheng X, Gong L, Xue W, Zeng S, Xu Y, Zhang Y, et al. Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis. AIDS Res Ther. 2019;16(1): 37. https:\/\/doi.org\/10.1186\/s12981-019-0253-z.","journal-title":"AIDS Res Ther"},{"issue":"8","key":"11480_CR13","doi-asserted-by":"publisher","first-page":"e0000463","DOI":"10.1371\/journal.pgph.0000463","volume":"2","author":"K Allel","year":"2022","unstructured":"Allel K, Jaoude GJA, Birungi C, Palmer T, Skordis J, Haghparast-Bidgoli H. Technical efficiency of National HIV\/AIDS spending in 78 countries between 2010 and 2018: a data envelopment analysis. PLoS Glob Public Health. 2022;2(8):e0000463. https:\/\/doi.org\/10.1371\/journal.pgph.0000463.","journal-title":"PLoS Glob Public Health"},{"issue":"12","key":"11480_CR14","doi-asserted-by":"publisher","first-page":"e0003979","DOI":"10.1371\/journal.pgph.0003979","volume":"4","author":"V Nkunu","year":"2024","unstructured":"Nkunu V, Tungsanga S, Diongole HM, Sarki A, Arruebo S, Caskey FJ, et al. Landscape of kidney replacement therapy provision in low- and lower-middle income countries: a multinational study from the ISN-GKHA. PLoS Glob Public Health. 2024;4(12):e0003979. https:\/\/doi.org\/10.1371\/journal.pgph.0003979.","journal-title":"PLoS Glob Public Health"},{"issue":"14","key":"11480_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJM199004053221401","volume":"322","author":"PA Volberding","year":"1990","unstructured":"Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS clinical trials group of the National Institute of allergy and infectious diseases. N Engl J Med. 1990;322(14):941\u20139. https:\/\/doi.org\/10.1056\/NEJM199004053221401.","journal-title":"N Engl J Med"},{"key":"11480_CR16","unstructured":"ROBINS-I tool | Cochrane Methods. https:\/\/methods.cochrane.org\/robins-i [Accessed 29 Dec 2024]."},{"issue":"3","key":"11480_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u201394. https:\/\/doi.org\/10.1111\/biom.12817.","journal-title":"Biometrics"},{"issue":"2","key":"11480_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I. Basic concepts and first analyses. Br J Cancer. 2003;89(2):232\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6601118.","journal-title":"Br J Cancer"},{"key":"11480_CR19","unstructured":"Survival Analysis. https:\/\/sphweb.bumc.bu.edu\/otlt\/MPH-Modules\/BS\/BS704_Survival\/BS704_Survival_print.html [Accessed 26 Nov 2023]."},{"key":"11480_CR20","doi-asserted-by":"publisher","DOI":"10.5281\/ZENODO.3509134","author":"The pandas development team","year":"2024","unstructured":"The pandas development team. pandas-dev\/pandas: pandas. Zenodo. 2024. https:\/\/doi.org\/10.5281\/ZENODO.3509134. [Accessed 14th September 2024].","journal-title":"Zenodo"},{"issue":"3","key":"11480_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in python. Nat Methods. 2020;17(3):261\u201372. https:\/\/doi.org\/10.1038\/s41592-019-0686-2.","journal-title":"Nat Methods"},{"key":"11480_CR22","doi-asserted-by":"publisher","unstructured":"Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with python. SciPy. 2010;7(1):92\u20136. https:\/\/doi.org\/10.25080\/Majora-92bf1922-011","DOI":"10.25080\/Majora-92bf1922-011"},{"issue":"3","key":"11480_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib. A 2D graphics environment. Comput Sci Eng. 2007;9(3):90\u20135. https:\/\/doi.org\/10.1109\/MCSE.2007.55.","journal-title":"Comput Sci Eng"},{"key":"11480_CR24","volume-title":"Python 3 reference manual","author":"G Van Rossum","year":"2009","unstructured":"Van Rossum G, Drake FL. Python 3 reference manual. Scotts Valley, CA: CreateSpace; 2009."},{"issue":"8","key":"11480_CR25","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1600-6143.2009.02684.x","volume":"9","author":"L Tricot","year":"2009","unstructured":"Tricot L, Teicher E, Peytavin G, Zucman D, Conti F, Calmus Y, et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant. 2009;9(8):1946\u201352. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02684.x.","journal-title":"Am J Transplant"},{"issue":"8","key":"11480_CR26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ckj\/sfaa231","volume":"14","author":"K El Sakhawi","year":"2021","unstructured":"El Sakhawi K, Melica G, Scemla A, Bertrand D, Garrouste C, Malvezzi P, et al. Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients. Clin Kidney J. 2021;14(8):1908\u201314. https:\/\/doi.org\/10.1093\/ckj\/sfaa231.","journal-title":"Clin Kidney J"},{"issue":"13","key":"11480_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1177\/0956462418779659","volume":"29","author":"G Alfano","year":"2018","unstructured":"Alfano G, Mori G, Fontana F, Dolci G, Baisi A, Ligabue G, et al. Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study. Int J STD AIDS. 2018;29(13):1305\u201315. https:\/\/doi.org\/10.1177\/0956462418779659.","journal-title":"Int J STD AIDS"},{"issue":"8","key":"11480_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/QAD.0000000000001457","volume":"31","author":"EN Gathogo","year":"2017","unstructured":"Gathogo EN, Shah S, Post FA. Kidney transplant outcomes in HIV serodiscordant recipient pairs. AIDS. 2017;31(8):1199\u2013201. https:\/\/doi.org\/10.1097\/QAD.0000000000001457.","journal-title":"AIDS"},{"issue":"1","key":"11480_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/archsurg.2008.508","volume":"144","author":"JE Locke","year":"2009","unstructured":"Locke JE. Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg. 2009;144(1):83. https:\/\/doi.org\/10.1001\/archsurg.2008.508.","journal-title":"Arch Surg"},{"issue":"4","key":"11480_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/01.TP.0000436905.54640.8c","volume":"97","author":"JE Locke","year":"2014","unstructured":"Locke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, et al. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation. 2014;97(4):446\u201350. https:\/\/doi.org\/10.1097\/01.TP.0000436905.54640.8c.","journal-title":"Transplantation"},{"issue":"4","key":"11480_CR31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ndt\/gfq592","volume":"26","author":"A Mazuecos","year":"2011","unstructured":"Mazuecos A, Fernandez A, Andres A, Gomez E, Zarraga S, Burgos D, et al. HIV infection and renal transplantation. Nephrol Dial Transplant. 2011;26(4):1401\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfq592.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"11480_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/tri.12147","volume":"26","author":"A Mazuecos","year":"2013","unstructured":"Mazuecos A, Fernandez A, Zarraga S, Andres A, Rodriguez-Benot A, Jimenez C, et al. High incidence of delayed graft function in HIV-infected kidney transplant recipients. Transpl Int. 2013;26(9):893\u2013902. https:\/\/doi.org\/10.1111\/tri.12147.","journal-title":"Transpl Int"},{"issue":"(2015)(S1)","key":"11480_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5414\/CNP83S0039","volume":"83","author":"E Muller","year":"2015","unstructured":"Muller E. ransplantation in resource-limited setting: using HIV-positive donors for HIV-positive patients. Clin Nephro. 2015;83((2015)(S1)):39\u201341. https:\/\/doi.org\/10.5414\/CNP83S0039.","journal-title":"Clin Nephro."},{"issue":"2","key":"11480_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","volume":"8","author":"ME Roland","year":"2008","unstructured":"Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008;8(2):355\u201365. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02061.x.","journal-title":"Am J Transplant"},{"issue":"5","key":"11480_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/tid.12592","volume":"18","author":"AR Vicari","year":"2016","unstructured":"Vicari AR, Spuldaro F, Sandes\u2010Freitas TV, Cristelli MP, Requi\u00e3o\u2010Moura LR, Reusing JO, et al. Renal transplantation in human immunodeficiency virus\u2010infected recipients: a case\u2013control study from the Brazilian experience. Transpl Infect Dis. 2016;18(5):730\u201340. https:\/\/doi.org\/10.1111\/tid.12592.","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"11480_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/tri.12167","volume":"26","author":"M Vivanco","year":"2013","unstructured":"Vivanco M, Friedmann P, Xia Y, Klair T, Marfo K, De Boccardo G, et al. Campath induction in HCV and HCV\/HIV-seropositive kidney transplant recipients. Transpl Int. 2013;26(10):1016\u201326. https:\/\/doi.org\/10.1111\/tri.12167.","journal-title":"Transpl Int"},{"issue":"6","key":"11480_CR37","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.ASN.0000127987.19470.3A","volume":"15","author":"KC Abbott","year":"2004","unstructured":"Abbott KC, Swanson SJ, Agodoa LYC, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol. 2004;15(6):1633\u20139. https:\/\/doi.org\/10.1097\/01.ASN.0000127987.19470.3A.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"11480_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/hiv.12700","volume":"20","author":"M Matignon","year":"2019","unstructured":"Matignon M, Leli\u00e8vre J, Lahiani A, Abbassi K, Desvaux D, Diallo A, et al. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the agence Nationale de recherche Sur Le Sida et Les h\u00e9patites virales (ANRS) 153 TREVE trial. HIV Med. 2019;20(3):202\u201313. https:\/\/doi.org\/10.1111\/hiv.12700.","journal-title":"HIV Med"},{"issue":"2","key":"11480_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ki.2015.74","volume":"88","author":"D Sawinski","year":"2015","unstructured":"Sawinski D, Forde KA, Eddinger K, Troxel AB, Blumberg E, Tebas P, et al. Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV\/HCV-coinfected recipients. Kidney Int. 2015;88(2):341\u20139. https:\/\/doi.org\/10.1038\/ki.2015.74.","journal-title":"Kidney Int"},{"issue":"1","key":"11480_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ajt.13922","volume":"17","author":"BA Shelton","year":"2017","unstructured":"Shelton BA, Mehta S, Sawinski D, Reed RD, MacLennan PA, Gustafson S, et al. Increased mortality and graft loss with kidney retransplantation among human immunodeficiency virus (HIV)\u2013infected recipients. Am J Transplant. 2017;17(1):173\u20139. https:\/\/doi.org\/10.1111\/ajt.13922.","journal-title":"Am J Transplant"},{"issue":"4","key":"11480_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0956462417726213","volume":"29","author":"O Ailioaie","year":"2018","unstructured":"Ailioaie O, Arzouk N, Valantin M, Tourret J, Calin R, Turinici M, et al. Infectious complications in HIV-infected kidney transplant recipients. Int J STD AIDS. 2018;29(4):341\u20139. https:\/\/doi.org\/10.1177\/0956462417726213.","journal-title":"Int J STD AIDS"},{"issue":"12","key":"11480_CR42","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1097\/01.tp.0000226074.97314.e0","volume":"81","author":"J Qiu","year":"2006","unstructured":"Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation. 2006;81(12):1658\u201361. https:\/\/doi.org\/10.1097\/01.tp.0000226074.97314.e0.","journal-title":"Transplantation"},{"key":"11480_CR43","doi-asserted-by":"publisher","unstructured":"Roland ME, Barin B, Huprikar S, Murphy B, Hanto DW, Blumberg E, et al. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS. 2015;1. https:\/\/doi.org\/10.1097\/QAD.0000000000000934.","DOI":"10.1097\/QAD.0000000000000934"},{"key":"11480_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.trim.2016.06.001","volume":"38","author":"MA Lorio","year":"2016","unstructured":"Lorio MA, Rosa R, Suarez JF, Ruiz P, Ciancio G, Burke GW, et al. Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients. Transpl Immunol. 2016;38:40\u20133. https:\/\/doi.org\/10.1016\/j.trim.2016.06.001.","journal-title":"Transpl Immunol"},{"issue":"10","key":"11480_CR45","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1016\/j.transproceed.2018.08.002","volume":"50","author":"S Apewokin","year":"2018","unstructured":"Apewokin S, Madan R, Restrepo A, Hemmige VS, Arora S. Clinical and health care utilization outcomes of kidney transplantation in HIV-positive recipients: a nationwide analysis from 2008\u20132013. Transplant Proc. 2018;50(10):3361\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2018.08.002.","journal-title":"Transplant Proc"},{"key":"11480_CR46","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. [eds]. Cochrane handbook for systematic reviews of interventions. 1st ed. Wiley; 2019. https:\/\/doi.org\/10.1002\/9781119536604. [Accessed 11 Dec 2023].","DOI":"10.1002\/9781119536604"},{"issue":"11","key":"11480_CR47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM199709113371102","volume":"337","author":"RM Gulick","year":"1997","unstructured":"Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337(11):734\u20139. https:\/\/doi.org\/10.1056\/NEJM199709113371102.","journal-title":"N Engl J Med"},{"issue":"7","key":"11480_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073659","volume":"25","author":"B Sever","year":"2024","unstructured":"Sever B, Otsuka M, Fujita M, Ciftci H. A review of FDA-approved anti-HIV-1 drugs, anti-Gag compounds, and potential strategies for HIV-1 eradication. Int J Mol Sci. 2024;25(7): 3659. https:\/\/doi.org\/10.3390\/ijms25073659.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11480_CR49","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/ajt.13758","volume":"16","author":"DA Axelrod","year":"2016","unstructured":"Axelrod DA, Naik AS, Schnitzler MA, Segev DL, Dharnidharka VR, Brennan DC, et al. National variation in use of immunosuppression for kidney transplantation: a call for evidence-based regimen selection. Am J Transplant. 2016;16(8):2453\u201362. https:\/\/doi.org\/10.1111\/ajt.13758.","journal-title":"Am J Transplant"},{"key":"11480_CR50","unstructured":"Advagraf | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/advagraf [Accessed 11 May 2025]."},{"issue":"9","key":"11480_CR51","first-page":"441","volume":"12","author":"MC Mueller","year":"2007","unstructured":"Mueller MC, Bogner JR. Treatment with CCR5 antagonists: which patient may have a benefit? Eur J Med Res. 2007;12(9):441\u201352.","journal-title":"Eur J Med Res"},{"issue":"12","key":"11480_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1358\/dot.2007.43.12.1146063","volume":"43","author":"TH Evering","year":"2007","unstructured":"Evering TH, Markowitz M. Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1. Drugs Today. 2007;43(12):865\u201377. https:\/\/doi.org\/10.1358\/dot.2007.43.12.1146063.","journal-title":"Drugs Today"},{"key":"11480_CR53","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1111\/tri.1992.5.s1.129","volume":"5","author":"V Delaney","year":"1992","unstructured":"Delaney V, Sumrani VN, Hong J, Davis R, Sommer B. The course of HIV disease in renal allograft recipients. Transpl Int. 1992;5:S129\u201332. https:\/\/doi.org\/10.1111\/tri.1992.5.s1.129.","journal-title":"Transpl Int"},{"issue":"7","key":"11480_CR54","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.transproceed.2012.07.082","volume":"44","author":"A Mazuecos","year":"2012","unstructured":"Mazuecos A, Rodriguez Benot A, Moreno A, Burgos D, Aguera M, Garcia Alvarez T, et al. Renal replacement therapy in patients with HIV infection in a European region: outcomes following renal transplantation. Transplant Proc. 2012;44(7):2053\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2012.07.082.","journal-title":"Transplant Proc"},{"issue":"8","key":"11480_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/TP.0b013e31820f081f","volume":"91","author":"SC Yoon","year":"2011","unstructured":"Yoon SC, Hurst FP, Jindal RM, George SA, Neff RT, Agodoa LY, et al. Trends in renal transplantation in patients with human immunodeficiency virus infection: an analysis of the United States renal data system. Transplantation. 2011;91(8):864\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e31820f081f.","journal-title":"Transplantation"},{"issue":"5","key":"11480_CR56","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0956462416651528","volume":"28","author":"MM Azar","year":"2017","unstructured":"Azar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. Int J STD AIDS. 2017;28(5):447\u201358. https:\/\/doi.org\/10.1177\/0956462416651528.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"11480_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12727","volume":"19","author":"SM Boyle","year":"2017","unstructured":"Boyle SM, Malat G, Harhay MN, Lee DH, Pang L, Talluri S, et al. Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients. Transpl Infect Dis. 2017;19(4): e12727. https:\/\/doi.org\/10.1111\/tid.12727.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"11480_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13253","volume":"22","author":"SM Boyle","year":"2020","unstructured":"Boyle SM, Fehr K, Deering C, Raza A, Harhay MN, Malat G, et al. Barriers to kidney transplant evaluation in HIV-positive patients with advanced kidney disease: a single\u2010center study. Transplant Infectious Dis. 2020;22(2): e13253. https:\/\/doi.org\/10.1111\/tid.13253.","journal-title":"Transplant Infectious Dis"},{"issue":"5","key":"11480_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13532","volume":"33","author":"JF Camargo","year":"2019","unstructured":"Camargo JF, Anjan S, Chin-Beckford N, Morris MI, Abbo LM, Simkins J, et al. Clinical outcomes in HIV+\/HCV\u2009+\u2009coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-year single center experience. Clin Transplant. 2019;33(5): e13532. https:\/\/doi.org\/10.1111\/ctr.13532.","journal-title":"Clin Transplant"},{"issue":"12","key":"11480_CR60","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ekir.2019.08.006","volume":"4","author":"JF Camargo","year":"2019","unstructured":"Camargo JF, Pallikkuth S, Moroz I, Natori Y, Alcaide ML, Rodriguez A, et al. Pretransplant levels of C-reactive protein, soluble TNF receptor-1, and CD38\u2009+\u2009HLADR\u2009+\u2009CD8 T cells predict risk of allograft rejection in HIV\u2009+\u2009kidney transplant recipients. Kidney Int Rep. 2019;4(12):1705\u201316. https:\/\/doi.org\/10.1016\/j.ekir.2019.08.006.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"11480_CR61","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/ajt.16205","volume":"21","author":"CM Durand","year":"2021","unstructured":"Durand CM, Zhang W, Brown DM, Yu S, Desai N, Redd AD, et al. A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant. 2021;21(5):1754\u201364. https:\/\/doi.org\/10.1111\/ajt.16205.","journal-title":"Am J Transplant"},{"key":"11480_CR62","unstructured":"Safety of Kidney Transplantation from Donors with HIV | New England Journal of Medicine. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2403733 [Accessed 26 Dec 2024]."},{"issue":"12","key":"11480_CR63","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","volume":"7","author":"LA Frassetto","year":"2007","unstructured":"Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant. 2007;7(12):2816\u201320. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02007.x.","journal-title":"Am J Transplant"},{"issue":"8","key":"11480_CR64","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/bdd.1860","volume":"34","author":"L Frassetto","year":"2013","unstructured":"Frassetto L, Floren L, Barin B, Browne M, Wolfe A, Roland M, et al. Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharm Drug Dispos. 2013;34(8):442\u201351. https:\/\/doi.org\/10.1002\/bdd.1860.","journal-title":"Biopharm Drug Dispos"},{"issue":"8","key":"11480_CR65","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1111\/ajt.13840","volume":"16","author":"LM Kucirka","year":"2016","unstructured":"Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, et al. Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus. Am J Transplant. 2016;16(8):2368\u201376. https:\/\/doi.org\/10.1111\/ajt.13840.","journal-title":"Am J Transplant"},{"issue":"9","key":"11480_CR66","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1681\/ASN.2014070726","volume":"26","author":"JE Locke","year":"2015","unstructured":"Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, et al. A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol. 2015;26(9):2222\u20139. https:\/\/doi.org\/10.1681\/ASN.2014070726.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"11480_CR67","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/ajt.13847","volume":"16","author":"JE Locke","year":"2016","unstructured":"Locke JE, Shelton BA, Reed RD, MacLennan PA, Mehta S, Sawinski D, et al. Identification of optimal donor\u2013recipient combinations among human immunodeficiency virus (HIV)\u2013positive kidney transplant recipients. Am J Transplant. 2016;16(8):2377\u201383. https:\/\/doi.org\/10.1111\/ajt.13847.","journal-title":"Am J Transplant"},{"issue":"1","key":"11480_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.ajkd.2018.02.352","volume":"73","author":"GE Malat","year":"2019","unstructured":"Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, et al. Kidney transplantation in HIV-positive patients: a single-center, 16-year experience. Am J Kidney Dis. 2019;73(1):112\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2018.02.352.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"11480_CR69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/TP.0b013e31827ac322","volume":"95","author":"T Muthukumar","year":"2013","unstructured":"Muthukumar T, Afaneh C, Ding R, Tsapepas D, Lubetzky M, Jacobs S, et al. HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation. 2013;95(5):711\u201320. https:\/\/doi.org\/10.1097\/TP.0b013e31827ac322.","journal-title":"Transplantation"},{"issue":"12","key":"11480_CR70","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/ajt.14419","volume":"17","author":"D Sawinski","year":"2017","unstructured":"Sawinski D, Shelton BA, Mehta S, Reed RD, MacLennan PA, Gustafson S, et al. Impact of protease inhibitor\u2013based anti-retroviral therapy on outcomes for HIV\u2009+\u2009kidney transplant recipients. Am J Transplant. 2017;17(12):3114\u201322. https:\/\/doi.org\/10.1111\/ajt.14419.","journal-title":"Am J Transplant"},{"issue":"2","key":"11480_CR71","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/01.TP.0000075973.73064.A6","volume":"76","author":"PG Stock","year":"2003","unstructured":"Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003;76(2):370\u20135. https:\/\/doi.org\/10.1097\/01.TP.0000075973.73064.A6.","journal-title":"Transplantation"},{"issue":"5","key":"11480_CR72","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/ajt.12699","volume":"14","author":"PG Stock","year":"2014","unstructured":"Stock PG, Barin B, Hatano H, Rogers RL, Roland ME, Lee TH, et al. Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. Am J Transplant. 2014;14(5):1136\u201341. https:\/\/doi.org\/10.1111\/ajt.12699.","journal-title":"Am J Transplant"},{"issue":"4","key":"11480_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13294","volume":"22","author":"G Alfano","year":"2020","unstructured":"Alfano G, Guaraldi G, Fontana F, Franceschini E, Dolci G, Mussini C, et al. Role of maraviroc in minimizing the risk of graft rejection in HIV-infected kidney transplant recipients. Transplant Infect Dis. 2020;22(4): e13294. https:\/\/doi.org\/10.1111\/tid.13294.","journal-title":"Transplant Infect Dis"},{"issue":"1","key":"11480_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s15010-017-1092-2","volume":"46","author":"I Izzo","year":"2018","unstructured":"Izzo I, Casari S, Bossini N, Forleo MA, Sandrini S, Foc\u00e0 E, et al. Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy). Infection. 2018;46(1):77\u201382. https:\/\/doi.org\/10.1007\/s15010-017-1092-2.","journal-title":"Infection"},{"issue":"6","key":"11480_CR75","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.transproceed.2011.05.024","volume":"43","author":"MN Martina","year":"2011","unstructured":"Martina MN, Cofan F, Suarez A, Masso E, Trullas JC, Cervera C, et al. Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patients. Transplant Proc. 2011;43(6):2179\u201381. https:\/\/doi.org\/10.1016\/j.transproceed.2011.05.024.","journal-title":"Transplant Proc"},{"issue":"2","key":"11480_CR76","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.transproceed.2019.12.009","volume":"52","author":"M Moreno-Ramirez","year":"2020","unstructured":"Moreno-Ramirez M, Villanego F, Vigara LA, Cazorla JM, Naranjo J, Garcia T, et al. Direct-acting antiretroviral therapy in renal transplant recipients with human immunodeficiency virus\u2013hepatitis C virus coinfection: report of our experience and literature review. Transplant Proc. 2020;52(2):523\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2019.12.009.","journal-title":"Transplant Proc"},{"issue":"10","key":"11480_CR77","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/j.1600-6143.2010.03258.x","volume":"10","author":"M Touzot","year":"2010","unstructured":"Touzot M, Pillebout E, Matignon M, Tricot L, Viard JP, Rondeau E, et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant. 2010;10(10):2263\u20139. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03258.x.","journal-title":"Am J Transplant"},{"key":"11480_CR78","unstructured":"World Bank Country and Lending Groups \u2013 World Bank Data Help Desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [Accessed 29 Dec 2024]."},{"issue":"4","key":"11480_CR79","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1681\/ASN.2017080853","volume":"29","author":"E Muller","year":"2018","unstructured":"Muller E, Barday Z. HIV-positive kidney donor selection for HIV-positive transplant recipients. J Am Soc Nephrol. 2018;29(4):1090\u20135. https:\/\/doi.org\/10.1681\/ASN.2017080853.","journal-title":"J Am Soc Nephrol"},{"key":"11480_CR80","unstructured":"A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/12228882\/ [Accessed 30 Dec 2024]."},{"key":"11480_CR81","unstructured":"Chapter 1. 0: Analysing data and undertaking meta-analyses. https:\/\/training.cochrane.org\/handbook\/current\/chapter-10 [Accessed 27 Dec 2024]."},{"issue":"3","key":"11480_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1034\/j.1399-3062.2002.01009.x","volume":"4","author":"Sj Swanson","year":"2002","unstructured":"Swanson Sj, Kirk Ad, Ko Cw, Jones Ca, Agodoa Ly, Abbott Kc, et al. Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. Transpl Infect Dis. 2002;4(3):144\u20137. https:\/\/doi.org\/10.1034\/j.1399-3062.2002.01009.x.","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"11480_CR83","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/ndt\/14.10.2455","volume":"14","author":"MA Gentil","year":"1999","unstructured":"Gentil MA, Rocha JL, Rodr\u00edguez-Algarra G, Pereira P, L\u00f3pez R, Bernal G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant. 1999;14(10):2455\u201360. https:\/\/doi.org\/10.1093\/ndt\/14.10.2455.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"11480_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/hep.510290123","volume":"29","author":"P Mathurin","year":"1999","unstructured":"Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 1999;29(1):257\u201363. https:\/\/doi.org\/10.1002\/hep.510290123.","journal-title":"Hepatology"},{"issue":"4","key":"11480_CR85","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00007890-199808270-00010","volume":"66","author":"T Hanafusa","year":"1998","unstructured":"Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation. 1998;66(4):471.","journal-title":"Transplantation"},{"issue":"1","key":"11480_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ije\/31.1.115","volume":"31","author":"P J\u00fcni","year":"2002","unstructured":"J\u00fcni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002;31(1):115\u201323. https:\/\/doi.org\/10.1093\/ije\/31.1.115.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"11480_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13499","volume":"33","author":"EA Blumberg","year":"2019","unstructured":"Blumberg EA, Rogers CC, American Society of Transplantation Infectious Diseases Community of Practice. Solid organ transplantation in the HIV-infected patient: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9): e13499. https:\/\/doi.org\/10.1111\/ctr.13499.","journal-title":"Clin Transplant"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11480-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11480-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11480-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:39:47Z","timestamp":1781609987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-11480-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11480"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11480-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This meta-analysis is registered on PROSPERO (CRD42024627233).This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.None of the organs were procured from executed prisoners in studies included in this systematic review and meta-analysis.All organs were procured after informed consent or authorization in studies included in this systematic review and meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1160"}}